136 related articles for article (PubMed ID: 9519902)
1. The ankyrin-binding domain of CD44s is involved in regulating hyaluronic acid-mediated functions and prostate tumor cell transformation.
Zhu D; Bourguignon LY
Cell Motil Cytoskeleton; 1998; 39(3):209-22. PubMed ID: 9519902
[TBL] [Abstract][Full Text] [Related]
2. Interaction of CD44 variant isoforms with hyaluronic acid and the cytoskeleton in human prostate cancer cells.
Welsh CF; Zhu D; Bourguignon LY
J Cell Physiol; 1995 Sep; 164(3):605-12. PubMed ID: 7544357
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of CD44 in pl85(neu)-transfected NIH3T3 cells promotes an up-regulation of hyaluronic acid-mediated membrane-cytoskeleton interaction and cell adhesion.
Zhu D; Bourguignon L
Oncogene; 1996 Jun; 12(11):2309-14. PubMed ID: 8649770
[TBL] [Abstract][Full Text] [Related]
4. Rho-kinase (ROK) promotes CD44v(3,8-10)-ankyrin interaction and tumor cell migration in metastatic breast cancer cells.
Bourguignon LY; Zhu H; Shao L; Zhu D; Chen YW
Cell Motil Cytoskeleton; 1999; 43(4):269-87. PubMed ID: 10423269
[TBL] [Abstract][Full Text] [Related]
5. Interaction between CD44 and the repeat domain of ankyrin promotes hyaluronic acid-mediated ovarian tumor cell migration.
Zhu D; Bourguignon LY
J Cell Physiol; 2000 May; 183(2):182-95. PubMed ID: 10737894
[TBL] [Abstract][Full Text] [Related]
6. Ankyrin-binding domain of CD44(GP85) is required for the expression of hyaluronic acid-mediated adhesion function.
Lokeshwar VB; Fregien N; Bourguignon LY
J Cell Biol; 1994 Aug; 126(4):1099-109. PubMed ID: 7519619
[TBL] [Abstract][Full Text] [Related]
7. Soluble CD44 inhibits melanoma tumor growth by blocking cell surface CD44 binding to hyaluronic acid.
Ahrens T; Sleeman JP; Schempp CM; Howells N; Hofmann M; Ponta H; Herrlich P; Simon JC
Oncogene; 2001 Jun; 20(26):3399-408. PubMed ID: 11423990
[TBL] [Abstract][Full Text] [Related]
8. N-terminal and central regions of the human CD44 extracellular domain participate in cell surface hyaluronan binding.
Liao HX; Lee DM; Levesque MC; Haynes BF
J Immunol; 1995 Oct; 155(8):3938-45. PubMed ID: 7561101
[TBL] [Abstract][Full Text] [Related]
9. CD44v(3,8-10) is involved in cytoskeleton-mediated tumor cell migration and matrix metalloproteinase (MMP-9) association in metastatic breast cancer cells.
Bourguignon LY; Gunja-Smith Z; Iida N; Zhu HB; Young LJ; Muller WJ; Cardiff RD
J Cell Physiol; 1998 Jul; 176(1):206-15. PubMed ID: 9618160
[TBL] [Abstract][Full Text] [Related]
10. Lipid-binding role of betaII-spectrin ankyrin-binding domain.
Bok E; Plazuk E; Hryniewicz-Jankowska A; Chorzalska A; Szmaj A; Dubielecka PM; Stebelska K; Diakowski W; Lisowski M; Langner M; Sikorski AF
Cell Biol Int; 2007 Dec; 31(12):1482-94. PubMed ID: 17716929
[TBL] [Abstract][Full Text] [Related]
11. CD44 interaction with ankyrin and IP3 receptor in lipid rafts promotes hyaluronan-mediated Ca2+ signaling leading to nitric oxide production and endothelial cell adhesion and proliferation.
Singleton PA; Bourguignon LY
Exp Cell Res; 2004 Apr; 295(1):102-18. PubMed ID: 15051494
[TBL] [Abstract][Full Text] [Related]
12. Interaction between CD44 and hyaluronic acid regulates human prostate cancer development.
Miyake H; Hara I; Okamoto I; Gohji K; Yamanaka K; Arakawa S; Saya H; Kamidono S
J Urol; 1998 Oct; 160(4):1562-6. PubMed ID: 9751413
[TBL] [Abstract][Full Text] [Related]
13. Hyaluronic acid-induced lymphocyte signal transduction and HA receptor (GP85/CD44)-cytoskeleton interaction.
Bourguignon LY; Lokeshwar VB; Chen X; Kerrick WG
J Immunol; 1993 Dec; 151(12):6634-44. PubMed ID: 7505012
[TBL] [Abstract][Full Text] [Related]
14. CD44v10 interaction with Rho-kinase (ROK) activates inositol 1,4,5-triphosphate (IP3) receptor-mediated Ca2+ signaling during hyaluronan (HA)-induced endothelial cell migration.
Singleton PA; Bourguignon LY
Cell Motil Cytoskeleton; 2002 Dec; 53(4):293-316. PubMed ID: 12378540
[TBL] [Abstract][Full Text] [Related]
15. Coexpression of CD44 variant (v10/ex14) and CD44S in human mammary epithelial cells promotes tumorigenesis.
Iida N; Bourguignon LY
J Cell Physiol; 1997 May; 171(2):152-60. PubMed ID: 9130462
[TBL] [Abstract][Full Text] [Related]
16. Role of CD44s and CD44v6 on human breast cancer cell adhesion, migration, and invasion.
Afify A; Purnell P; Nguyen L
Exp Mol Pathol; 2009 Apr; 86(2):95-100. PubMed ID: 19167378
[TBL] [Abstract][Full Text] [Related]
17. Binding of CD44 to hyaluronic acid can be induced by multiple signals and requires the CD44 cytoplasmic domain.
Liu D; Zhang D; Mori H; Sy MS
Cell Immunol; 1996 Nov; 174(1):73-83. PubMed ID: 8929456
[TBL] [Abstract][Full Text] [Related]
18. Hyaluronan binding by CD44 is regulated by a phosphorylation-independent mechanism.
Uff CR; Neame SJ; Isacke CM
Eur J Immunol; 1995 Jul; 25(7):1883-7. PubMed ID: 7542594
[TBL] [Abstract][Full Text] [Related]
19. Role of CD44 cytoplasmic domain in hyaluronan binding.
Perschl A; Lesley J; English N; Trowbridge I; Hyman R
Eur J Immunol; 1995 Feb; 25(2):495-501. PubMed ID: 7533087
[TBL] [Abstract][Full Text] [Related]
20. Site-specific de-N-glycosylation of CD44 can activate hyaluronan binding, and CD44 activation states show distinct threshold densities for hyaluronan binding.
English NM; Lesley JF; Hyman R
Cancer Res; 1998 Aug; 58(16):3736-42. PubMed ID: 9721887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
